Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A 4-year-old boy with a rare type of rickets and hair loss improved in bone health but not hair growth after vitamin D and calcium treatment.

CYP11A1 is crucial for skin health and disease by producing important steroids.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Biotinidase deficiency can mimic other conditions, making early diagnosis and treatment crucial to prevent lasting issues.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

wAMD patients have higher oxidative stress, suggesting antioxidant treatment may help.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Lack of a certain enzyme causes hair to grey early by damaging stem cells, but an antioxidant can help prevent this.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Lack of vitamin D receptor increases skin tumor risk by boosting hedgehog signaling.

17β-estradiol can reduce inflammation in the skin.

Compound 4 is a promising treatment for hair loss with low toxicity.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Riboflavin is essential for health and growth, and its deficiency causes serious health issues.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Fibroblasts from healthy donors can prevent changes seen in recessive epidermolysis bullosa simplex.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.